Company news

Pentixapharm Holding AG news in 2025

Pentixapharm Holding AG's news releases, calls and decks from 2025, newest first.

View company

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

December 3, 2025

Financial document (Q3 Prasentation Earnings Call Pentixapharm Holding AG 85dk)

November 14, 2025

Financial document (Q3 Prasentation Earnings Call Pentixapharm Holding AG 37hw)

November 14, 2025

Pentixapharm Publishes 9-Month Figures for 2025

November 12, 2025

Financial document (Pentixapharm Q3 2025 e)

November 11, 2025

Pentixapharm to Report Third Quarter and First Nine Months 2025 Financial Results on Wednesday, November 12, 2025

November 10, 2025

Pentixapharm Holding AG: Pentixapharm significantly reduces projected loss for financial year 2025

November 6, 2025

Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure

October 23, 2025

Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025

October 6, 2025

Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial

September 26, 2025

Decks in 2025